Nannan Wu

机构：Morpho (United States), Fudan University, Southwest Medical University, Shanghai CASB Biotechnology (China), Shanghai Public Health Clinical Center, Heilongjiang Bayi Agricultural University · ORCID：0000-0003-1244-0030

发表论文 96 篇 · 总被引 2052 次 · h-index 24

代表论文

• Regulations of phage therapy across the world (2023 · Frontiers in Microbiology · 被引 167)
• Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy (2023 · Clinical Microbiology and Infection · 被引 77)
• Associate toxin-antitoxin with CRISPR-Cas to kill multidrug-resistant pathogens (2023 · Nature Communications · 被引 48)
• Personalized bacteriophage therapy for chronic biliary tract Pseudomonas aeruginosa infections (2025 · hLife · 被引 21)
• PB-LKS: a python package for predicting phage–bacteria interaction through local K-mer strategy (2024 · Briefings in Bioinformatics · 被引 17)
• Rapid and precise treatment selection for antimicrobial-resistant infection enabled by a nano-dilution SlipChip (2024 · Biosensors and Bioelectronics · 被引 15)